Gsk (GSK) Inventory Average (2009 - 2026)
Gsk (GSK) posted quarterly Inventory Average of $8.4 billion for Q2 2026, up 6.85% year-over-year from $7.8 billion in Q2 2025, and up 3.39% quarter-over-quarter from $8.1 billion in Q1 2026.
Gsk (GSK) Inventory Average (2009 - 2026) Analysis & Trends
Gsk's Inventory Average history runs 18 years deep, the most recent figure standing at $8.4 billion for Q2 2026.
- In Q2 2026, Inventory Average rose 6.85% year-over-year to $8.4 billion; the TTM figure through Jun 2026 stood at $8.4 billion (up 6.85% YoY), while the FY2025 annual figure was $7.5 billion, up 6.9% from the prior year.
- Inventory Average for Q2 2026 stood at $8.4 billion, up from $8.1 billion in the prior quarter.
- The five-year high for Inventory Average was $8.4 billion in Q2 2026, with the low at $3.6 billion in Q2 2022.
- The 5-year median for Inventory Average is $7.2 billion (2024), against an average of $6.9 billion.
- The sharpest annual moves came in 2022 and 2023: Inventory Average plunged 58.69% in 2022, then surged 86.29% in 2023.
- Gsk's Inventory Average stood at $5.8 billion in 2022, then climbed by 19.42% to $6.9 billion in 2023, then advanced by 8.72% to $7.5 billion in 2024, then grew by 7.82% to $8.1 billion in 2025, then climbed by 3.68% to $8.4 billion in 2026.
- Business Quant data shows GSK's Inventory Average at $8.4 billion in Q2 2026, $8.1 billion in Q1 2026, and $8.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.85 Bn | 625.09 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 464.52 Bn | 457.95 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 371.03 Bn | 363.89 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 298.88 Bn | 291.19 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.79 Bn | 250.89 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 234.78 Bn | 220.79 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 179.58 Bn | 176.40 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 159.12 Bn | 147.42 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 104.71 Bn | 100.55 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Sanofi | 54.65 Bn | 47.27 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.36 Bn |
| Mar 31, 2026 | 8.09 Bn |
| Dec 31, 2025 | 8.07 Bn |
| Sep 30, 2025 | 8.18 Bn |
| Jun 30, 2025 | 7.83 Bn |
| Mar 31, 2025 | 7.42 Bn |
| Dec 31, 2024 | 7.48 Bn |
| Sep 30, 2024 | 7.54 Bn |
| Jun 30, 2024 | 7.31 Bn |
| Mar 31, 2024 | 7.03 Bn |
| Dec 31, 2023 | 6.88 Bn |
| Sep 30, 2023 | 6.92 Bn |
| Jun 30, 2023 | 6.70 Bn |
| Mar 31, 2023 | 6.27 Bn |
| Dec 31, 2022 | 5.76 Bn |
| Sep 30, 2022 | 5.68 Bn |
| Jun 30, 2022 | 3.60 Bn |
| Mar 31, 2022 | 4.56 Bn |
| Dec 31, 2021 | 8.20 Bn |
| Sep 30, 2021 | 8.73 Bn |